Liver disease and other comorbidities in Wolcott-Rallison syndrome: different phenotype and variable associations in a large cohort.

Thumbnail
URI
http://hdl.handle.net/11287/618183
Author
Habeb, A. M.
Deeb, A.
Johnson, M.
Abdullah, M.
Abdulrasoul, M.
Al-Awneh, H.
Al-Maghamsi, M. S. F.
Al-Murshedi, F.
Al-Saif, R.
Al-Sinani, S.
Ramadan, D.
Tfayli, H.
Flanagan, Sarah
Ellard, Sian
Date
2015-04
Journal
Hormone Research in Paediatrics
Type
Journal Article
Clinical Trial
Multicenter Study
Research Support, Non-U.S. Gov't
Publisher
Karger
DOI
10.1159/000369804
Rights
Archived with thanks to Hormone research in pædiatrics
Metadata
Show full item record
Abstract
Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction has been reported in 60% of patients.
Citation
Liver disease and other comorbidities in Wolcott-Rallison syndrome: different phenotype and variable associations in a large cohort. 2015, 83 (3):190-7 Horm Res Paediatr
Publisher URL
http://www.karger.com/?DOI=10.1159/000369804
Note
This article is freely available via Open Access. Click on the 'Additional Link' above to access the full text.
Collections